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Healthcare-associated infections in Australia: Tackling the ‘known
unknowns’
Philip L. Russo; Allen C. Cheng; Brett G. Mitchell; Lisa Hall
Abstract. Australia does not have a national healthcare-associated infection (HAI)
surveillance program. Without national surveillance, we do not understand the burden of
HAIs, nor can we accurately assess the effects of national infection prevention initiatives.
Recent research has demonstrated disparity between existing jurisdictional-based HAI
surveillance activity while also identifying broad key stakeholder support for the
establishment of a national program. A uniform surveillance program will also address
growing concerns about hospital performance measurements and enable public reporting of
hospital data.
Introduction
Healthcare-associated infections (HAIs) cause significant morbidity and mortality.1 Most are
believed to be preventable,2 but prevention requires an understanding of how, why and
where HAIs are occurring. An HAI surveillance program informs such knowledge.
Surveillance of HAIs is fundamental to any infection prevention program and provides data
on which to develop an infection-prevention program.3 Many major countries with large,
complex healthcare systems, including the US, England, Scotland, Germany, France and
The Netherlands, all have well-established and mature national HAI surveillance programs.4
European countries even contribute HAI data to the European Centres for Disease Control
to improve their understanding of HAIs in the region.5 Many of these national programs
comprise elements mandating specific HAI data be submitted to a national database.
Although many local and some state-wide surveillance programs do exist in Australia, these
have evolved separately and recent research has demonstrated there is broad variation in
activity, methodology, skill, reporting and agreement in identifying infections.4,6,7 This
means that meaningful comparisons of HAI data between states and territories, and the
generation of national data, is not possible, preventing the use of data to inform policy. As a
result, the current national burden of HAIs is unknown in Australia. The last national HAI
prevalence survey took place in 1984.8
Why do we need national HAI surveillance?
We propose three important reasons why Australia should have a national HAI surveillance
program. The first relates to patient safety, and the right of the consumer to expect the same
quality of care wherever they present. The risk of acquiring an HAI should not be dependent
on the size or location of the facility a patient attends. It is likely an increased risk of HAI will
not be due to patient characteristics or other explainable causes, such as the type of
interventions received, but for other, yet to be identified, reasons. Presently, we do not know
anything about facilities with higher HAI rates or why HAIs are occurring. We need to identify
these HAIs so we can then start to understand the cause, share successful initiatives and
implement action at a national level to prevent further infections. This will improve health
care safety and quality for all. The second reason relates to performance and measurement.
Funders have a right to expect that healthcare facilities are making informed and wise
decisions based on sound data to direct precious infection-prevention resources
appropriately. Regulatory bodies expect that facilities under their jurisdiction are providing
safe care, and accreditors need to know that the processes and outcomes they review are
valid measures of safety and quality. Although the Australian Institute for Health and Welfare
has now assumed responsibility for the public release of hospital performance indicators,
including a single HAI (Staphylococcus aureus bacteraemia), published on the MyHospitals
website (www.myhospitals.gov.au, accessed 13 February 2017), the fact remains that the
usefulness of this information remains extremely limited until we have a coordinated
approach and a uniform method to measure other HAI outcomes nationally.

The third reason is about identifying effective interventions. Australia has undertaken several
national infection-prevention activities over recent years. The National Hand Hygiene
Initiative (NHHI)9 was implemented several years ago and now collates data from over 900
Australian healthcare facilities. The National Guidelines on Infection Prevention and
Control,10 originally released in 2010, are currently undergoing review and provide a
national infection prevention resource for many facilities.
The National Safety and Quality Health Service Standard 3 is completely devoted to
infection prevention and safety by providing guidance and infection-prevention standards to
facilities. 11 The overall aim of each of these resource-intense national activities is ultimately
to reduce the burden of HAIs, but the disparity within current HAI surveillance means we
cannot accurately measure their effectiveness, or identify and prioritise areas for future
intervention.
What needs to be done?
A recent study involving key stakeholders across Australia demonstrated overwhelming
support for a national HAI surveillance program, which the stakeholders believed would be
beneficial to their hospital infection-prevention programs.12 The same study also identified
that key stakeholders would prefer a mandatory national program that enabled hospitals to
compare data with like hospitals, as well as a national benchmark. Further, there was a
strong preference for hospital HAI data to be released publicly on a routine basis.12
Despite the support of many stakeholders, there are many challenges that must be
addressed. From a clinical and epidemiological viewpoint, key issues for an HAI surveillance
program are reasonably straightforward and include robust data collection processes,
appropriate risk adjustment, timely feedback and validation.
Other challenges will be political. For example, issues regarding data governance would
need to be addressed, and uniform response strategies would need to be coordinated
between states and territories. There is a growing trend internationally with performance
measurement, public reporting and financial penalties for low-performing hospitals. Financial
penalties associated with HAIs are already common in the US.13 It could be argued that
‘pay for performance’ may result in a ‘race to the bottom’ as poorly resourced services are
penalised with no information on process failure on which to act. Further, if targets are met,
there is little incentive to introduce new initiatives, especially if those require additional
resources.14 Already in Australia Queensland has instituted financial penalties for
preventable bloodstream infections in the absence of public reporting.15 Recently, an
Australian private health fund announced a policy of non-payment for ‘hospital-acquired
complications’, including HAI.16 All these challenges will need to be identified and
addressed through a comprehensive implementation strategy to ensure that surveillance
findings translate into improved patient outcomes.17 There is precedent with national
infection prevention initiatives, such as the NHHI, and the submission of national data, such
as the HAI S. aureus data published on the MyHospitals website (www.myhospitals.gov.au,
accessed 13 February 2017).
There is ample experience and expertise in HAI surveillance in Australia in the existing statewide programs, in both implementation and maintenance of programs. Given international
trends, it is inevitable that there will be an increased demand for transparency in healthcare
quality metrics in Australia. A national HAI surveillance program would enable this.
A new initiative will require a recalibration of current funding of infection prevention in
Australia. Recent Australian studies have suggested that staffing costs for infection
prevention nurses exceed AUD$100million per year, and that 36% of their time is spent on
surveillance.18,19 A separate study identified that half of those undertaking surveillance had
never been trained, and fundamental elements, such as risk adjustment and reporting data
to hospital executives, is frequently not done.7 This means that much of the HAI data being
collected is not being analysed in a meaningful way, and because it is not being reported to
those with authority to make change, HAI data are not being used for action. Clearly a
proportion of precious infection prevention resources are not being used efficiently and a

need for capacity building in this area is essential. These resources need to be redirected
towards best practice.
Efficiencies are also likely from an ‘economies of scale’ argument. A uniform national
approach to surveillance means there will be no duplication between states and territories,
and rather than develop local interventions, national interventions would similarly prevent
duplication.
Further, although the implementation of current and future national infection prevention
initiatives is welcome, it makes both clinical and economic sense to invest some of these
resources towards establishing a national surveillance program so the effect of these
initiatives can be measured appropriately.
Conclusion
There are clear benefits for all stakeholders from a national HAI surveillance program.
Australia has the expertise and the support from many of the key stakeholders who
understand the benefits at a hospital level. Commitment and strong national leadership is
required to bring the states and territories together to identify an appropriate implementation
strategy to ensure success.
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